Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug
source: pixabay.com

Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug

According to a story from pm360online.com, the Orion Corporation, a pharmaceutical company based in Finland, has recently announced that it plans to continue its Phase 3 trial of levosimendan as…

Continue Reading Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug
Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA
www_slon_pics / Pixabay

Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA

According to a story from finanznachrichten.de, the Swedish drug company Calliditas Therapeutics has recently announced that the US Food and Drug Administration (FDA) has given one of the company's experimental drugs…

Continue Reading Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA

Potential Gene Therapy for Late Infantile Batten Disease Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the biotechnology company REGENXBIO, Inc. recently announced that its experimental gene therapy candidate called RGX-181 has been granted Rare Pediatric Disease designation from the…

Continue Reading Potential Gene Therapy for Late Infantile Batten Disease Earns Rare Pediatric Disease Designation

This Just In: Patient Reported Experiences are Important for Research in Osteogenesis Imperfecta

What is osteogenesis imperfecta? Osteogenesis imperfecta (OI) actually refers to a group of four distinct rare disorders- OI Type I, II, III, and IV. They're all characterized by brittle bones which…

Continue Reading This Just In: Patient Reported Experiences are Important for Research in Osteogenesis Imperfecta
This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies
FotografieLink / Pixabay

This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies

According to a story from Reuters, a new website developed by the American Gastroenterological Association is meant to help women that have inflammatory bowel disease have safe and healthy pregnancies.…

Continue Reading This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies
Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
cocoparisienne / Pixabay

Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

According to a story from WebMD, the rare nervous system disorder chronic inflammatory demyelinating polyneuropathy is notorious for being difficult to diagnose. Many rare diseases can be challenging to identify.…

Continue Reading Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

Study Shows Treatment may be Effective for Chronic Kidney Disease but Increase Risk of Hyperkalemia

A recent study, called TOPCAT, evaluated the effects of spironolactone as a treatment for individuals living with Chronic Kidney Disease (CKD) who are also diagnosed with heart failure with preserved ejection fraction,…

Continue Reading Study Shows Treatment may be Effective for Chronic Kidney Disease but Increase Risk of Hyperkalemia
Importance of Patient-Centered Research in Familial Chylomicronemia Syndrome
source: pixabay.com

Importance of Patient-Centered Research in Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome (FCS) Is a rare disease caused by malfunctioning lipoprotein lipase. This results in a buildup of triglycerides in the body's plasma. FCS can cause pancreatitis, memory loss, nerve…

Continue Reading Importance of Patient-Centered Research in Familial Chylomicronemia Syndrome

Her Brother Participated in Trials for Vital Spinal Muscular Atrophy Drug, and Now She’s Denied Treatment Access

According to a story from mirror.co.uk, a five-month-old girl named Maryam Malji was diagnosed with spinal muscular atrophy, a progressive, degenerative disease that is ultimately fatal without treatment. Her brother…

Continue Reading Her Brother Participated in Trials for Vital Spinal Muscular Atrophy Drug, and Now She’s Denied Treatment Access

You Can Provide Suggestions for the FDA’s Revision of their Rare Disease Research Guidelines

Time for Revision Like many things in this world, research for rare diseases such as Spinal Muscular Atrophy (SMA), Multiple Sclerosis, and Duchenne Muscular Dystrophy (DMD) has evolved substantially in recent years. This evolution…

Continue Reading You Can Provide Suggestions for the FDA’s Revision of their Rare Disease Research Guidelines